Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Powders for inhalation|
|Abstract:||In order to control and optimize the amount of inhalable active substance released when drugs are administered as inhalation powders, the invention calls for the use of auxiliaries consisting of mixtures of coarser particles (average particle size>20 .mu.m) and finer particles (average particle size<10 .mu.m).|
|Inventor(s):||Arnold; Klaus (Ingelheim am Rhein, DE), Grass; Peter (Ingelheim am Rhein, DE), Knecht; Adolf (Freiburg, DE), Roos; Robert (Ingelheim am Rhein, DE), Sluke; Gerhard (Ingelheim am Rhein, DE), Thieme; Herbet (Ingelheim am Rhein, DE), Wenzel; Joachim (Ingelheim am Rhein, DE)|
|Assignee:||Boehringer Ingelheim KG (Ingelheim am Rhein, DE)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Austria||164060||<disabled in preview>|
|Australia||3085492||<disabled in preview>|
|Australia||670555||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.